[1] Bonekamp D,Horton KM,Hruban RH,et al.Castleman disease:The great mimic［J］.Radiographics,2011,31(6):1793-1807.
[2] Castleman B,Iverson L,Menendez VP.Localized mediastinal lymphnode hyperplasia resembling thymoma［J］.Cancer,1956,9(4):822-830.
[3] Wang C,Zhou J,Ma Z,et al.CT and MRI Features and pathological characteristics of retroperitoneal localized Castleman's disease［J］.Chinese Journal of Oncology,2014,36(3):193-197.
[4] Xiao L,Zhang ZL,Liu YB,et al.CT and MRI features of Castleman's disease of the abdomen and pelvis［J］.Journal of Souther Medical University,2011,31(1):129-132.
[5] Munshi N,Mehra M,Van de Velde H,et al.Use of a claims database to characterize and estimate the incidence rate for Castleman disease［J］.Leuk Lymphoma,2015,56(5):1252-1260.
[6] Keller AR,Hochholzer L,Castleman B.Hyaline-vascular and plasma types of giant lymph node hyperplasia of the mediastinum and other locations［J］.Cancer,1972,29(3):670-683.
[7] Talat N,Belgaumkar AP,Schulte KM.Surgery in Castleman's disease:A systematic review of 404 published cases［J］.Annals of Surgery,2012,255(4):677-684.
[8] Lv A,Hao C,Qian H,et al.Castleman disease of the mesentery as the great mimic:Incidental finding of one case and the literature review［J］.Biosci Trends,2015,9(3):198-202.
[9] Polizzotto MN,Uldrick TS,Wang V,et al.Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease［J］.Blood,2013,122(26):4189-4198.
[10] Sbihi Z,Dossier A,Boutboul D,et al.iNKT and memory B-Cell alterations in HHV-8 multicentric Castleman disease［J］.Blood,2017,129(7):855-865.
[11] Uldrick TS.iNKT cell defects in HHV-8-associated MCD［J］.Blood,2017,129(7):806-807.
[12] Kawabata H,Kadowaki N,Nishikori M,et al.Clinical features and treatment of multicentric castleman's disease:A retrospective study of 21 Japanese patients at a single institute［J］.J Clin Exp Hematop,2013,53(1):69-77.
[13] Wakabayashi K,Asanuma K,Takeda Y,et al.Hyaline vascular type of unicentric Castleman's disease with proliferation of glomerular endothelial cells［J］.Clinical Nephrology,2014,81(6):445-450.
[14] Bracale U,Pacelli F,Milone M,et al.Laparoscopic treatment of abdominal unicentric castleman's disease:A case report and literature review［J］.Bmc Surgery,2017,17(1):38.
[15] Dispenzieri A,Gertz MA.Treatment of Castleman's disease［J］.Curr Treat Options Oncol,2005,6(3):255-266.
[16] Nagubandi R,Wang Y,Dutcher JP,et al.Classic case of unicentric mixed-type Castleman's disease［J］.J Clin Oncol,2013,31(36):e452-455.
[17] Casper C.The aetiology and management of Castleman disease at 50 years:Translating pathophysiology to patient care［J］.Br J Haematol,2005,129(1):3-17.
[18] Bucher P,Chassot G,Zufferey G,et al.Surgical management of abdominal and retroperitoneal Castleman's disease［J］.World J Surg Oncol,2005,3:33.
[19] Malara F,Price D,Fabiny R.Mesenteric Castleman's disease:Ultrasound,computed tomography and angiographic appearance［J］.Australas Radiol,2000,44(1):109-111.
[20] Madan R,Chen JH,Trotman-Dickenson B,et al.The spectrum of Castleman's disease:Mimics,radiologic pathologic correlation and role of imaging in patient management［J］.Eur J Radiol,2012,81(1):123-131.
[21] Zhou LP,Zhang B,Peng WJ,et al.Imaging findings of Castleman disease of the abdomen and pelvis［J］.Abdom Imaging,2008,33(4):482-488.
[22]Guthrie PJ,Thomas JV,Deniz P,et al.Perivesical unicentric Castleman disease initially suspected to be metastatic prostate cancer［J］.Urology Annals,2016,8(2):245-248.
[23]Lee ES,Paeng JC,Park CM,et al.Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clinical implication［J］.Clinical Nuclear Medicine,2013,38(5):339-342.
[24] Ding Q,Zhang J,Yang L.18F-FDG PET/CT in multicentric Castleman disease:A case report［J］.Ann Transl Med,2016,4(3):58.
[25] Allen-Auerbach M,Vos SD,Czernin J.PET/computed tomography and lymphoma［J］.Radiologic Clinics of North America,2013,51(5):833-844.
[26] Dale E,Moan JM,Osnes TA,et al.Cervical lymph node metastases of squamous cell carcinoma of unknown origin:The diagnostic value of FDG PET/CT and clinical outcome［J］.Eur Arch Otorhinolaryngol,2017,274(2):1015-1019.
[27] Behnia F,Elojeimy S,Matesan M,et al.Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome［J］.Annals of Hematology,2017,96(3):497-500.